The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
News Medical on MSN6h
Radiation and immunotherapy help preserve bladders in patients with muscle-invasive bladder cancerPatients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
Layoffs, funding freezes, and executive orders spark outcry among federal researchers and university partners, fearing that ...
Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.
In the second phase of the research, the team validated the accuracy and universality of the technology through clinical studies involving 200 patients with diabetes and 30 healthy individuals.
Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 –– ...
A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...
In the second phase of the research, the team validated the accuracy and universality of the technology through clinical studies involving 200 diabetes patients and 30 healthy individuals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback